Open Access<p>Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression</p>
Author(s) -
Farid Chekani,
Holly M. Holmes,
Michael L. Johnson,
Hua Chen,
Jeffrey T. Sherer,
Rajender R. Aparasu
Publication year - 2020
Publication title -
drug, healthcare and patient safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 24
ISSN - 1179-1365
DOI - 10.2147/dhps.s226486
Subject(s) - quetiapine , medicine , asenapine , ziprasidone , olanzapine , antipsychotic , risperidone , aripiprazole , clozapine , psychiatry , atypical antipsychotic , depression (economics) , incidence (geometry) , pediatrics , schizophrenia (object oriented programming) , physics , economics , macroeconomics , optics
According to the 2015 American Geriatrics Society (AGS) Beers criteria, most antipsychotics are inappropriate in Parkinson's disease (PD) patients due to the risk of worsening Parkinsonian symptoms. This study examined the incidence and predictors of inappropriate antipsychotic use among long-term care residents with PD and comorbid depression.